Neuberger Berman Group LLC Purchases 450,648 Shares of Revvity Inc. $RVTY

Neuberger Berman Group LLC raised its position in shares of Revvity Inc. (NYSE:RVTY) by 4,598.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 460,447 shares of the company’s stock after buying an additional 450,648 shares during the quarter. Neuberger Berman Group LLC’s holdings in Revvity were worth $40,358,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. First National Advisers LLC raised its holdings in shares of Revvity by 0.8% during the 3rd quarter. First National Advisers LLC now owns 15,023 shares of the company’s stock worth $1,317,000 after acquiring an additional 125 shares in the last quarter. FWG Holdings LLC grew its holdings in shares of Revvity by 2.8% in the third quarter. FWG Holdings LLC now owns 6,215 shares of the company’s stock valued at $592,000 after purchasing an additional 167 shares in the last quarter. NorthCrest Asset Manangement LLC grew its holdings in shares of Revvity by 2.5% in the third quarter. NorthCrest Asset Manangement LLC now owns 7,514 shares of the company’s stock valued at $685,000 after purchasing an additional 180 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in Revvity by 25.9% in the second quarter. EverSource Wealth Advisors LLC now owns 900 shares of the company’s stock worth $87,000 after purchasing an additional 185 shares during the last quarter. Finally, Leslie Global Wealth LLC increased its position in Revvity by 9.3% in the second quarter. Leslie Global Wealth LLC now owns 2,195 shares of the company’s stock worth $212,000 after purchasing an additional 186 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity Stock Down 5.5%

Shares of RVTY opened at $91.28 on Friday. The company has a quick ratio of 1.40, a current ratio of 1.68 and a debt-to-equity ratio of 0.36. The business has a fifty day moving average of $103.15 and a 200 day moving average of $96.61. The company has a market cap of $10.21 billion, a PE ratio of 43.88, a P/E/G ratio of 2.05 and a beta of 1.10. Revvity Inc. has a 52-week low of $81.36 and a 52-week high of $120.39.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million for the quarter, compared to analysts’ expectations of $759.81 million. During the same quarter in the previous year, the business posted $1.42 earnings per share. The business’s revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, sell-side analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is currently 13.46%.

Analysts Set New Price Targets

Several equities analysts have commented on RVTY shares. Barclays increased their price objective on shares of Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Tuesday, February 3rd. Robert W. Baird set a $129.00 target price on shares of Revvity in a report on Tuesday, February 3rd. JPMorgan Chase & Co. upped their target price on shares of Revvity from $100.00 to $105.00 and gave the company a “neutral” rating in a research report on Tuesday, February 3rd. TD Cowen reaffirmed a “hold” rating on shares of Revvity in a report on Tuesday, February 3rd. Finally, Evercore lifted their price target on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 3rd. Five equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, Revvity has a consensus rating of “Hold” and a consensus target price of $113.67.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.